Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2009) 19 P83

SFEBES2009 Poster Presentations Clinical practice/governance and case reports (87 abstracts)

Screening for primary aldosteronism in a secondary care diabetes population

S Steven , J Mettayil & J Chapman


Department of Metabolic Medicine, City Hospitals Sunderland NHS Foundation Trust, Sunderland, UK.


Introduction: Hypertension remains a significant co-morbidity in the population with diabetes, with a prevalence of 20–60%. In type 2 diabetes, hypertension is often present as part of the metabolic syndrome of insulin resistance. In type 1 diabetes, hypertension may reflect the onset of diabetic nephropathy.

Aims: To investigate the prevalence of, and to stratify, hypertension in our diabetes clinic population. To investigate prevalence of risk factors meriting further investigation for primary aldosteronism in this target population.

Standards: The Endocrine Society Guidelines (2008) on screening for primary aldosteronism and the Joint National Commission 6th Guideline (1997) on stratifying hypertension.

Exclusion criteria: Presence of diabetic nephropathy.

Method: Retrospective data collection on 119 patients who attended the diabetes clinic in October 2008. Of 19% were excluded: 16 had diabetic nephropathy; three had incomplete documentation.

Results: Hundred patients were included (42 males and 58 females); type 1 diabetes – 24%, type 2 diabetes – 71%, secondary diabetes – 4% and other – 1%. The mean patient age was 56.8 years (range 29–79). Using the Joint National Committee stages of hypertension, 45% were not hypertensive, 30% had stage 1, 16% stage 2 and 9% stage 3 hypertension. Four patients had drug resistant hypertension: blood pressure more than 140 mmHg systolic and 90 mmHg diastolic despite three antihypertensive medications. Twenty one percent were on no anti-hypertensive, 33% on one, 22% on two, 15% on three, 7% on four and 2% on five. Only one patient was hypokalaemic (potassium<3.5 mmol/l) and hypertensive. Twenty five percent of patients fulfilled criteria for screening for primary aldosteronism, all by virtue of their stage 2 (16%) or stage 3 (9%) hypertension. None of these patients had plasma renin-aldosterone ratios measured.

Conclusions: Hypertension remains a significant and difficult to treat problem in the diabetic population. Twenty five percent of patients merit further screening to investigate for possible primary aldosteronism.

Article tools

My recent searches

No recent searches.